Significant reduction in deaths from hepatitis C in England, UK Health Security Agency reports

March 3, 2022

A new report issued today by the UK Health Security Agency has revealed that there has been considerable progress in eliminating hepatitis C as a public health problem in England, with deaths from the virus falling by 35% between 2015 and 2020.  The number of people with chronic hepatitis C has also declined to approximately 81,000 in 2020 (compared to 129,000 in 2015) – a 37% fall in the general population.

Pamela Healy, Chief Executive of the British Liver Trust said, “There is now an effective cure for everyone living with hepatitis C and the significant decline in deaths and cases is encouraging.

“The challenge now is for us to find the thousands who are currently undiagnosed. Our message is if you have ever dabbled with drugs (even when you were much younger), practiced unsafe sex or had a tattoo while travelling abroad please get yourself tested just to make sure – the virus has no symptoms in the early stages.

“Just as importantly, if we are to meet the World Health Organisations target of elimination by 2030, we need urgent action to tackle the drug problem in the UK so that new people do not become infected.”

Modelling indicates that, of the 81,000 people estimated to have this chronic infection in England, around:

  • 27% of the chronic infections are in people who have recently injected drugs
  • 62% are in those with a past drug injecting history but who are no longer injecting
  • 11% are in those with no history of injecting drug use

Hepatitis C virus (HCV) is a bloodborne virus that can cause life-threatening liver disease, including cancer.  However, those infected often have no symptoms until many years later when their liver has been badly damaged.  When symptoms do occur, they can often be non-specific, like tiredness or loss of appetite, and be dismissed or mistaken for other conditions.

Andrew, 47 years old, a former hepatitis C patient based in Scotland: “I was surprised to learn that I had hepatitis C.  I got tested a couple of times before and was negative. I learned about it by chance.  I was in the hospital on an unrelated matter and got blood taken, and my liver results were a bit abnormal.  I got my drugs worker to test me and I found out that I was positive for hepatitis C.  I was devastated.  I even thought that I was going to die.  Luckily, the modern treatment is superb.

“I started my course of tablets immediately after learning that I’d got hepatitis C, and when I got tested again in 12 weeks, to my relief, I’d been cured.  To anyone in a similar situation, get tested. Do it to get that piece of mind for yourself.”

Dr Helen Harris, Clinical Scientist at the UK Health Security Agency, said: “In England, we are on our way to eliminating hepatitis C as the number of deaths continue to decline, and direct acting antiviral drugs are available that will clear the virus in around 95% of people who complete treatment.

“But many people remain undiagnosed, often because they have no symptoms or are unaware that they have ever been at risk.  If you have ever injected drugs – even if it happened only once or years ago – you could be at risk of hepatitis C.  If you think you could be at risk, speak to your GP and get a free test.”

Read the full report here: https://www.gov.uk/government/publications/hepatitis-c-in-the-uk

You can also find out if you are at risk by taking online quiz –  visit www.britishlivertrust.org.uk/screener.”

 

 

 

 

 

More news

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.   In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval

New hope for people living with MASH as two treatments receive MHRA approval

People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.